Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$77.71 billion in 2024 and an impressive US$110.39 billion by ...